Clinical Trials on Moderate Hypertriacylglycerolemic Subjects in Australia
Total 74 results
-
Protagonist Therapeutics, Inc.Completed
-
Tavotek BiotherapeuticsActive, not recruiting
-
GlaxoSmithKlineCompleted
-
NeuShen TherapeuticsRecruiting
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty LtdCompleted
-
BeBetter Med IncCompleted
-
Hoffmann-La RocheCompleted
-
InSilico Medicine Hong Kong LimitedRecruiting
-
Alebund Pty LtdCompletedHealthy SubjectsAustralia
-
Alebund Pty LtdCompleted
-
CelltrionCompletedHealthy Male SubjectsAustralia
-
Connect Biopharma Australia Pty LtdCompletedHealthy Adult SubjectsAustralia
-
Shanghai Vinnerna Biosciences Co., Ltd.Withdrawn
-
Trinomab Biotech Co., Ltd.TIGERMED AUSTRALIA PTY LIMITEDCompletedHealthy Adult SubjectsAustralia
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
Croma-Pharma GmbHCompleted
-
Medical University of ViennaUnknownHealthy SubjectsAustria
-
GlaxoSmithKlineCompletedHealthy Subjects | AnaemiaAustralia
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Daniel DobererCompletedHealthy Subjects | Heme OxygenaseAustria
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
GlaxoSmithKlineCompletedHealthy Subjects | Infections, BacterialAustralia
-
Medical University of ViennaCompletedHealthy Subjects | Imparied Retinal Vascular ReactivityAustria
-
Daniel DobererCompletedHealthy Subjects | Genetic Polymorphism | Heme OxygenaseAustria
-
Bristol-Myers SquibbCompleted
-
Medical University of ViennaVienna University of TechnologyUnknownModulation of Cardiovascular Parameters and Sympathovagal Balance in Healthy SubjectsAustria
-
Alvotech Swiss AGCompletedHealthy Male SubjectsSouth Africa, Australia, New Zealand
-
GlaxoSmithKlineCompletedAtherosclerosis | Healthy SubjectsAustralia
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsAustralia
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
AIT Austrian Institute of Technology GmbHCardiomed Kardiologisches Rehabilitationszentrum GmbH Linz; PKA Private Krankenanstalt... and other collaboratorsUnknownEvaluation of Multi-modal Supportive Actions in Outpatient Cardiac Rehabilitation in Subjects With Cardiovascular DiseaseAustria
-
Medical University of ViennaCompletedHealthy Human Male SubjectsAustria
-
Pieris Australia Pty LtdCompletedStudy of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy SubjectsHealthy SubjectsAustralia
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
Hospira, now a wholly owned subsidiary of PfizerCompletedMechanically Ventilated and Intubated SubjectsUnited States, Australia, Argentina, Brazil, New Zealand
-
Actinogen MedicalRecruitingAlzheimer Disease | Dementia, Mild | Dementia ModerateAustralia
-
Fundación Pública Andaluza Progreso y SaludKarolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaboratorsCompletedHealthy SubjectsFrance, Austria, Germany, Portugal, Hungary, Belgium, Italy, Spain, Switzerland
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Debiopharm International SACompletedModerate Alzheimer's DiseaseAustralia, Canada, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Medical University of ViennaRecruitingTo Investigate the Effect of 100% Oxygen Breathing on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Healthy SubjectsAustria
-
Medical University of ViennaCompletedDepressive; Episode, Major | Recurrent Depressive Disorder, Current Episode Moderate | Recurrent Depressive Disorder, Current Episode MildAustria
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Medical University of ViennaCompletedDiabetic Retinopathy | Retinal Vein Occlusion | Healthy SubjectsAustria
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Cognition TherapeuticsNational Institute on Aging (NIA)Active, not recruitingMild to Moderate Alzheimer's DiseaseUnited States, Australia, Netherlands, Czechia, Spain
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland